Partners
Partners

Partner 34 - QIAGEN GmbH


 

Dr. Markus Sprenger-Haussels

 

Senior Director

Head of Sample Technology Development Life Sciences

phone:+49 2103 2911696


undefined E-Mail

 

 

QIAGEN GmbH

 

QIAGEN Strasse 1

40724 Hilden

Germany

 

undefinedWebsite

CANCER-ID Team QIAGEN

Dr. Martin Schlumpberger

 

Scientific Associate Director

RNA Product Development

phone: +49 2103 2916288

 

undefinedE-Mail

 

 

Dr. Jonathan Shaffer

 

Associate Director

BRC product development America

phone: +1 301 6735178

 

undefinedE-Mail

 

 

Dr. Francesca di Pasquale

 

Associate Principal Scientist

miRNA Product Development

phone: +49 2103 2916187

 

undefinedE-Mail

 

 

Dr. Siegfried Hauch

 

Director

CTC Product Development

phone: +49 2103 2916245

 

undefinedE-Mail

Dr. Daniel Groelz

 

Scientific Associate Director

PreAnalytiX Tissue & Liquid Biopsy Samples

phone: +49 2103 2916213

 

undefinedE-Mail

Dr. Uwe Oelmueller

 

Vice President

MDx Development EU Sample Technologies

phone: +49 2103 2911489

 

undefinedE-Mail

Company presentation

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The application field of liquid biopsies is one of the key focus areas driving QIAGENs product development initiatives to provide new innovative Sample to insight solutions. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharma and biotech companies) and Academia (life sciences research). As of June 30, 2016, QIAGEN employed approximately 4,600 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

 

 

CANCER-ID Consortium

CANCER-ID consortium

CANCER-ID Workpackages

CANCER-ID Work Plan

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

Hands-on courses provided by our member TATAA Read more

Social Media

LinkedIn Cancer-ID